*Please note that we are no longer accepting clients for Risperdal claims
Risperdal is a powerful antipsychotic drug that is commonly prescribed to adults and children for the treatment of schizophrenia, bipolar disorder, autism, and behavioral problems. Risperdal is manufactured by Johnson and Johnson and was approved for adult use in 1994. It was not approved for use in children until 2006.
Risperdal has been linked to a condition called gynecomastia, which is the growth of excessive male breast tissue and galactorrhea, which is when milk is produced by male breasts. Gynocomastia and Galactorrhea are both caused the excess prolactin levels. Prolactin is the hormone that enables mammals to produce milk.
If you or a loved one has experienced male breast growth after taking Risperdal, connect with our Risperdal attorney from Shapiro Legal Group, PLLC. We offer free consultations online or by calling (888)640-3784.
Why Choose Us for Your Risperdal Attorney?
- Mark Shapiro, our founding mass tort attorney, has been handling cases, such as Risperdal for more than 20 years.
- We only specialize in mass tort litigation, giving us insight and specialized knowledge to handle your case.
- At Shapiro Legal Group, PLLC, our Risperdal lawyer ensures that any negligent parties are held responsible for your injuries by pursuing the maximum possible compensation you need to make a full recovery.
Gynocomastia Symptoms
- Pain and tenderness
- Production of breast milk (galactorrhea)
- Nipple discharge
- Severe weight gain
- Sexual dysfunction
- Endocrine system damage
- Pituitary tumors
Risperdal Fines and Lawsuits
Johnson & Johnson agreed to pay an FDA fine of $2.2 billion, over $1 billion to state governments for the illegal, off-label, promotion of Risperdal to children. Johnson & Johnson is also facing thousands of Risperdal lawsuits from boys who developed gynocomastia as a result of taking Risperdal. The company has already settled some of these cases and has also been found liable by juries in several cases that have gone to trial.